Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
Clear Skin, Clear Path: Transforming Psoriasis Care with Durable Biologic and Oral IL-23 Innovations
June 12, 2026
Denver, Colorado
June 12, 2026 Denver, Colorado
06:30 PM - 07:30 PM ET
Retina Rumble: Debating Modern Treatment Options
Roger A. Goldberg, MD, MBA
Christina Y. Weng, MD, MBA, FASRS
Yasha S. Modi, MD
Incorporating Novel Muscarinic Agents for Schizophrenia Into Clinical Practice: Overcoming Clinical Inertia
May 28, 2026
Miami Beach, Florida
07:00 AM - 08:00 AM ET
The Future of HNSCC: Aligning Teams, Transforming Care
Ravindra Uppaluri, MD, PhD
Nancy Lee, MD, FASTRO
Target Locked in gMG: Why T2T Matters
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Seeing the Invisible: Radiologic Precision to Enable Early Intervention in Bronchiectasis
May 13, 2026
06:00 PM - 07:00 PM ET
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
Orlando, Florida
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Turning Flares Into Function: Flag Uncontrolled Disease
Minimal By Design: Define MSE Endpoints
The IgG Clock: Redose Using IgG Kinetics
The 2-Point Signal: Apply ≥2-Point Rule
When to Begin FcRn: Initiation Criteria, Key Evidence
The 4-Hit Hypothesis: Foundations of IgAN Pathogenesis
Richard Lafayette, MD, FACP
APRIL Uncovered: An Upstream Driver in IgAN
Dana Rizk, MD
Hong Zhang
Shared Goals, Shared Gains: Align With Patient Preferences
Beyond RAASi and Approved Therapies: The Unmet Needs in IgAN
Emerging Evidence: IgAN Disease-Modifying Agents
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.